Data / Form D filings / CNS THERAPEUTICS INC
CNS THERAPEUTICS INC: Form D filings
CNS THERAPEUTICS INC, a pharmaceuticals company in St. Paul, MN, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on April 28, 2011, reports $3.1 million sold of a $3.1 million offering to 7 investors.
Find out what CNS THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 332 MINNESOTA STREET, SUITE W1750, St. Paul, MN, 55101
- Phone
- (651) 207-6959
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1439036
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2011 | Amendment | $3,050,000 | $3,050,000 | $0 | 7 | Dec 21, 2010 | sec.gov |
| Jan 4, 2011 | New notice | $3,000,000 | $3,000,000 | $0 | 6 | Dec 21, 2010 | sec.gov |
| Aug 20, 2009 | New notice | $7,000,000 | $7,000,000 | $0 | 7 | Aug 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nina Kjellson | Director | |
| Peter McNerney | Director | |
| Andrew LaFrence | Executive Officer, Promoter | |
| Pratik Shah | Director | |
| Howard Rosen | Director | |
| Richard Penn | Executive Officer, Promoter | |
| John Foster | Executive Officer, Director, Promoter |
Every Form D from the week of Apr 25, 2011 · All recent filings in Minnesota · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CNS THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.